Thank you for your interest in the Brocade 3 study. This study is currently enrolling patients with HER2- metastatic or locally advanced unresectable BRCA-associated breast cancer. Information on the Brocade 3 study’s design, eligibility criteria, outcomes and site locations can be found in this website. Study information can also be found on www.ClinicalTrials.gov, identifier NCT02163694.

Click here to see a list of participating physicians! Call 844-893-5525 or email AbbVie@emergingmed.com for more information!